HEMATOLOGICAL MALIGNANCIES – COMPREHENSIVE MEDICAL ONCOLOGY NOTES
🩸 HEMATOLOGICAL MALIGNANCIES – COMPREHENSIVE MEDICAL ONCOLOGY NOTES
Master the fundamentals and clinical management of five major hematological malignancies with the OncoNotes 2024 comprehensive notes collection.
📚 DISEASES COVERED
1️⃣ ACUTE MYELOID LEUKEMIA (AML)
- WHO and ICC classification
- ELN risk stratification
- Molecular and cytogenetic abnormalities
- Diagnosis and workup
- Intensive chemotherapy (7+3, CPX-351)
- Venetoclax-based regimens
- FLT3 and IDH inhibitors
- APL management
- Allogeneic stem cell transplantation
- Relapsed/refractory AML
2️⃣ CHRONIC MYELOID LEUKEMIA (CML)
- Pathophysiology and BCR::ABL1
- Diagnosis and disease phases
- ELN recommendations
- First-, second- and later-generation TKIs
- Molecular monitoring and response criteria
- Treatment-free remission
- TKI resistance and mutation analysis
- Management of TKI toxicities
3️⃣ CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
- IWCLL diagnostic criteria
- Rai and Binet staging
- FISH and molecular prognostic markers
- TP53 and IGHV assessment
- Indications for treatment
- BTK inhibitors and BCL-2 inhibitors
- Fixed-duration versus continuous treatment
- Relapsed/refractory CLL
- Richter transformation
4️⃣ DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
- Classification and molecular subtypes
- GCB versus ABC classification
- Diagnostic workup and staging
- IPI and CNS-IPI
- First-line treatment: R-CHOP and Pola-R-CHP
- CNS prophylaxis
- Primary refractory and relapsed disease
- CAR-T cell therapy
- Bispecific antibodies
- Important clinical trials
5️⃣ FOLLICULAR LYMPHOMA (FL)
- Classification and histological grading
- Diagnosis and staging
- FLIPI and FLIPI-2
- Indications for treatment
- Watchful waiting versus active treatment
- Rituximab-based regimens
- Bendamustine-based treatment
- Maintenance therapy
- Relapsed/refractory follicular lymphoma
- Targeted therapies and newer treatment approaches
🎯 WHAT MAKES THESE NOTES USEFUL?
✔️ Written in easy-to-understand language.
✔️ Systematically organised disease-wise.
✔️ Important information presented through structured text and summary tables.
✔️ Clinical approach to diagnosis and treatment.
✔️ Guideline-oriented content.
✔️ Important clinical trials and treatment concepts.
✔️ Useful for both conceptual learning and quick revision.
👨⚕️ WHO SHOULD READ THESE NOTES?
- DM/DrNB Medical Oncology residents and aspirants
- MD/DNB Radiation Oncology residents
- Clinical Oncologists
- Medical Oncologists
- Clinical Hematologists
- Residents preparing for oncology examinations
📖 OUR OBJECTIVE
To make complex hematological malignancies easier to understand by presenting extensive medical information in a structured, readable and clinically relevant format.
ONCONOTES 2024
Simplifying Medical Oncology, One Topic at a Time.
Total Pages: 96